facebook
TradedTraded
    Home
    Deals
    Newsletter
    Articles
    PropTech
    Partners


Messages

Go Pro
+ Submit+ Submit
All Deals
May 14, 2025 - Deals

Agree.com Raises $7.2 Million Seed Round Led By Pelion Venture Partners

Property Image
Agree.com, an AI-powered e-signature platform founded in February 2024 by CEO Marty Ringlein, has raised a $7.2M seed round led by Pelion Venture Partners to challenge incumbents like DocuSign and Bill.com. Unlike traditional tools, Agree.com integrates invoicing and payments directly into its contract workflow, offering free e-signatures while monetizing transaction fees. The company, which has already attracted over 25,000 users, was co-founded by startup veterans Ringlein, Will Hubbard (COO), and Eva INVESTORS: Pelion Venture Partners, Blank Ventures, Gokul Rajaram, Better Tomorrow Ventures, 8-Bit Capital, Trust Fund, Hustle Fund, Everywhere Ventures, Singh Capital Partners & Firsthand VC ROUND: Seed AMOUNT: $7,200,000 HQ: #SanFrancisco #California #VentureCapital #MartyRinglein #Agreecom #PelionVenturePartners #BlankVentures #GokulRajaram #BetterTomorrowVentures #8BitCapital #TrustFund #HustleFund #EverywhereVentures #SinghCapitalPartners #FirsthandVC #TradedVC

Property Image
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC